Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Murphy, Gregory F. [R-NC-3]

Rep. Murphy, Gregory F. [R-NC-3]

United States · Official source

Records

993 records where Rep. Murphy, Gregory F. [R-NC-3] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 4333 (119th)referred

Qualified to Serve Act

United States · United States Congress · 10 July 2025

Bill· HRH.R. 4317 (119th)referred

PBM Reform Act of 2025

United States · United States Congress · 10 July 2025

Bill· HRH.R. 4238 (119th)open

DLARA

United States · United States Congress · 27 June 2025

Disaster Loan Accountability and Reform Act or the DLARA This bill modifies the Small Business Administration (SBA) disaster loan program to require additional oversight and reports regarding the program. First, the bill requires the SBA to report monthly on the operation of the disaster loan program. (Currently, the SBA must report only during the applicable period for a major disaster.) The report must estimate the date on which available funding for such loans will reach 10% of the most recent appropriation and the date on which the funds will be depleted. If a report is not submitted by the required date, no funds may be obligated for official travel by the SBA Administrator until the report is submitted.  Second, the President's annual budget must include separate statements regarding the appropriations request for SBA disaster loans and COVID-19 Economic Injury Disaster Loans (EIDL), including explanations for any difference between the amount requested and the 10-year average cost for such loans. Third, the SBA must notify Congress when the unobligated balance of amounts available for disaster loans is less than 10% of the 10-year average annual cost provided in the most recent presidential budget. Finally, the bill requires additional oversight of the disaster loan program, including Government Accountability Office reports on the disbursement of disaster loans and the cost of specified SBA rules that modified the loan program; and an SBA report on its actions to improve forecasting, data quality, and budget assumptions for the cost of disaster loans.

Bill· HRH.R. 3886 (119th)referred

Veterans PTSD Screening Act

United States · United States Congress · 10 June 2025

Veterans PTSD Screening Act This bill requires the Department of Veterans Affairs (VA) to study through FY2027 whether RNA sequencing can be used to effectively diagnose veterans with inflammation or cellular stress (symptoms of post-traumatic stress disorder). The VA must submit to Congress a report on the results of the study.

Bill· HRH.R. 3579 (119th)referred

Veterans Readiness and Employment Program Integrity Act

United States · United States Congress · 23 May 2025

Veterans Readiness and Employment Program Integrity Act This bill modifies the Veteran Readiness and Employment (VR&E) program of the Department of Veterans Affairs (VA). The VR&E program provides job training and employment-related services to veterans with service-connected disabilities. The bill requires veterans to submit an application to the VA in order to receive an initial evaluation to participate in the VR&E program. Further, a veteran may not receive employment assistance under the VR&E program for more than 365 days. The bill also requires the VA to report to Congress regarding the employment of veterans who participate in a vocational rehabilitation program under the VR&E program, including the annual wages of veterans before and after completion of a program. Additionally, the VA must annually publish the average time between the date on which a veteran requests a vocational rehabilitation program under the VR&E program and the date on which they first meet with a counselor as part of the program. Finally, the VA must seek to enter into a contract with a non-VA entity that has expertise in vocational rehabilitation to review, report, and provide recommendations on rehabilitation programs under the VR&E program.

Bill· HRH.R. 3514 (119th)reported

Improving Seniors’ Timely Access to Care Act of 2025

United States · United States Congress · 20 May 2025

Improving Seniors' Timely Access to Care Act of 2025 This bill establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans. Specifically, MA plans must (1) establish an electronic prior authorization program that meets specified standards; (2) annually submit to the CMS for publication specified prior authorization information, including the percentage of requests approved and the average response time; and (3) meet other standards, as set by the Centers for Medicare & Medicaid Services (CMS), relating to the quality and timeliness of prior authorization determinations. The CMS and the Office of the National Coordinator for Health Information Technology must publish on the CMS' website a report that analyzes the information received from MA plans, the feasibility of implementing real-time decision making with respect to prior authorization requests, and the impact of decisions that are made using artificial intelligence on patient access. 

Bill· HRH.R. 3221 (119th)referred

ICELAND Act

United States · United States Congress · 6 May 2025

Bill· HRH.R. 3161 (119th)referred

Preventing Environmental Hazards Act of 2025

United States · United States Congress · 1 May 2025

Preventing Environmental Hazards Act of 2025 This bill expands National Flood Insurance Program (NFIP) coverage to include the demolition or relocation of certain coastal structures that are facing imminent collapse or subsidence. Specifically, NFIP must pay for demolition or relocation for NFIP-insured structures that are condemned or deemed unsafe by state or local authorities due to the threat of imminent collapse or subsidence from shoreline erosion or that meet other location criteria. The bill sets forth provisions for the valuation of the structure, the maximum claim to be paid, and the terms of coverage termination. This bill applies to structures covered by NFIP (1) for a period of 12 months on or before the date of the bill’s enactment, or (2) for a continuous period of 4 years prior to certification for coverage established by this bill.

Bill· HRH.R. 3028 (119th)referred

Duty Drawback Clarification Act

United States · United States Congress · 24 April 2025

Duty Drawback Clarification Act This bill revises Chapter 22 of the Harmonized Tariff Schedule of the United States to provide a uniform rate of duty for all whiskies.

Bill· HRH.R. 2902 (119th)referred

SOAR Act of 2025

United States · United States Congress · 10 April 2025

Supplemental Oxygen Access Reform Act of 2025 or the SOAR Act of 2025 This bill establishes certain requirements with respect to the payment and provision of supplemental oxygen and related services under Medicare. For example, the bill provides for separate payments, indexed to inflation, of oxygen and related equipment, supplies, and services under Medicare (rather than under the competitive acquisition program). It also specifically covers services that are provided by respiratory therapists under Medicare and provides for an additional payment adjustment for these services. Additionally, the bill (1) requires the Centers for Medicare & Medicaid Services to develop an electronic template for providers to use when prescribing oxygen and related equipment, supplies, and services; and (2) establishes certain rights for beneficiaries receiving these items and services, such as the right to choose their suppliers and to receive clear communications and be informed about the services provided.

Bill· HRH.R. 2715 (119th)referred

Destruction of Hazardous Imports Act

United States · United States Congress · 8 April 2025

Destruction of Hazardous Imports Act This bill expands the Food and Drug Administration’s (FDA’s) authority to require the destruction of certain items that are refused import into the United States and pose a risk to public health. Under current law, imported food, drugs, medical devices, tobacco products, and cosmetics are subject to FDA review. If an imported item is deficient in a specified manner (e.g., counterfeit, misbranded, or manufactured under insanitary conditions), the item is generally refused admission to the United States. An item refused admission may generally be exported, except that the FDA may destroy a drug, medical device, or tobacco product that is valued under $2,500 without the opportunity for export. Under the bill, the FDA may order the destruction, without the opportunity for export, of any food, drug, medical device, tobacco product, or cosmetic that is refused admission if the item presents a significant public health concern. If such an order is issued, the item’s owner or consignee must destroy it within 90 days at their own cost. The bill also prohibits the unauthorized movement (e.g., export) of an item subject to a destruction order. A violator is subject to a fine, a prison term of up to one year, or both. The FDA must promulgate regulations to carry out these provisions. These regulations must provide for due process for the owner or consignee of an item subject to a destruction order, including notice and an opportunity to appear before the item is destroyed.

Bill· HRH.R. 2605 (119th)open

SAVES Act

United States · United States Congress · 2 April 2025

Bill· HRH.R. 2433 (119th)passed

Reducing Medically Unnecessary Delays in Care Act of 2025

United States · United States Congress · 27 March 2025

Reducing Medically Unnecessary Delays in Care Act of 2025 This bill requires Medicare coverage decisions, including prior authorization requirements and adverse coverage decisions, to be based on written clinical criteria that is developed in consultation with physicians.

Bill· HRH.R. 2213 (119th)referred

Medical Supply Chain Resiliency Act

United States · United States Congress · 18 March 2025

Medical Supply Chain Resiliency Act This bill authorizes actions to facilitate trade in medical goods (i.e., medical devices, pharmaceutical goods, or inputs for such devices or goods). Specifically, the bill authorizes the President to (1) negotiate, enter into, and enforce a trusted trade partner agreement with a country or countries with respect to medical goods; and (2) proclaim a modification of any existing duty, a continuance of existing duty-free or excise treatment, or additional duties to carry out the trade agreement. These actions may only be taken if the President determines, based on specified considerations, that the reciprocal elimination of existing duties or other import restrictions with respect to medical goods would contribute to U.S. national security and public health.  A trusted trade partner agreement may include certain provisions, such as those to (1) reduce or eliminate duties, quotas, or other trade barriers; (2) diversify and expand supplier networks to secure a reliable supply of medical goods; and (3) harmonize regulatory procedures. Not later than 60 days before initiating negotiations with a trusted trade partner, the President must submit written notice to Congress. The bill requires congressional consultation and review of these trade agreements. A trade agreement shall not take effect if, during the required review period, Congress enacts a joint resolution of disapproval. The Office of the U.S. Trade Representative must monitor compliance by a trusted trade partner with the trade agreement's commitments and obligations. Further, the President may take certain actions in response to a failure to comply.

Bill· HRH.R. 2102 (119th)referred

Major Richard Star Act

United States · United States Congress · 14 March 2025

Bill· HRH.R. 2120 (119th)referred

ROCR Value Based Program Act

United States · United States Congress · 14 March 2025

Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care  means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later. Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions. The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.

Bill· HRH.R. 2048 (119th)referred

Metastatic Breast Cancer Access to Care Act

United States · United States Congress · 11 March 2025

Metastatic Breast Cancer Access to Care Act This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). Specifically, the bill eliminates the 5-month waiting period for SSDI benefits and the subsequent 24-month waiting period for Medicare coverage for individuals with metastatic breast cancer. Under current law, individuals generally must wait 5 months after the onset of disability to begin receiving SSDI benefits and an additional 24 months to become eligible for Medicare.

Bill· HRH.R. 2062 (119th)referred

To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for other purposes.

United States · United States Congress · 11 March 2025

This bill provides that amounts paid for membership in a health care sharing ministry, including amounts paid for the sharing of medical expenses and administrative fees, are a tax-deductible medical expense. (Health care sharing ministries are faith-based organizations with members who share a common set of ethical or religious beliefs and who contribute regular payments to cover the medical expenses of other members.)

Bill· HRH.R. 2028 (119th)referred

REDI Act

United States · United States Congress · 11 March 2025

Resident Education Deferred Interest Act or the REDI Act This bill allows borrowers in medical or dental internships or residency programs to defer student loan payments until the completion of their programs.

Bill· HRH.R. 2071 (119th)referred

Save Our Shrimpers Act

United States · United States Congress · 11 March 2025

Save Our Shrimpers Act This bill prohibits federal funds from being made available to international financial institutions (e.g., the International Monetary Fund) for financing activities related to foreign shrimp farms. The bill also requires an annual report on compliance by U.S. leadership of international financial institutions with policies to oppose financing for certain commodities or minerals. Specifically, the bill requires the Department of the Treasury to condition any provision of federal funds to an international financial institution on the requirement that the funds not be used to finance any activity related to shrimp farming, shrimp processing, or the export of shrimp in any foreign country. Under current law, Treasury must instruct U.S. leadership of international financial institutions to oppose providing financial assistance for the production or extraction of any commodity or mineral for export if (1) the commodity or mineral is in surplus on world markets, and (2) the export of such commodity or mineral will cause substantial injury to U.S. producers of a competing commodity or mineral (or of the same or a similar commodity or mineral). This bill requires the Government Accountability Office to investigate and annually report to Congress on the extent to which U.S. leadership at these institutions have carried out Treasury's instructions.